Headline is not correct it. Progen has now tripled since May and...

Headline is not correct it. Progen has now tripled since May and given last nights performance on NASDAQ it is well on its way to being a 4 banger since May. Not bad for a stock that no one seems to know about and attracts no interest whatsoever in these so called traders forums. So it just must be the long term holders prepared to take the view that Progen has something going for it and is therefore worth investing in. Put simply Progen has developed a portfolio of cancer types that its compound PI-88 looks like it can be effective against, with trials in various stages of progress and completion in Phase 1 and 2 being conducted in Australia the US and Taiwan. The next event for Progen appears to be a licensing agreement between themselves and a large overseas pharma to take PI-88 into Phase 3 testing.

redgumme